Literature DB >> 16344347

Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.

Chiara A Boito1, Paola Melacini, Andrea Vianello, Paola Prandini, Bruno F Gavassini, Alessia Bagattin, Gabriele Siciliano, Corrado Angelini, Elena Pegoraro.   

Abstract

BACKGROUND: Limb-girdle muscular dystrophy type 2I is caused by mutations in the fukutin-related protein gene (FKRP). FKRP encodes a putative glycosyltransferase protein that is involved in alpha-dystroglycan glycosylation.
OBJECTIVES: To identify patients with limb-girdle muscular dystrophy type 2I and to derive genotype-phenotype correlations.
DESIGN: Two hundred fourteen patients who showed muscle histopathologic features consistent with muscular dystrophy or myopathy of unknown etiology were studied. The entire 1.5-kilobase FKRP coding sequence from patient DNA was analyzed using denaturing high-performance liquid chromatography of overlapping polymerase chain reaction products, followed by direct sequencing of heteroduplexes.
RESULTS: Thirteen patients with limb-girdle muscular dystrophy type 2I (6% of all patients tested) were identified by FKRP mutation analysis, and 7 additional patients were identified by family screening. Six missense mutations (1 novel) were identified. The 826C>A nucleotide change was a common mutation, present in 35% of the mutated chromosomes. Clinical presentations included asymptomatic hyperCKemia, severe early-onset muscular dystrophy, and mild late-onset muscular dystrophy. Dilated cardiomyopathy and ventilatory impairment were frequent features. Significant intrafamilial and interfamilial clinical variability was observed.
CONCLUSIONS: FKRP mutations are a frequent cause of limb-girdle muscular dystrophies. The degree of respiratory and cardiac insufficiency in patients did not correlate with the severity of muscle involvement. The finding of 2 asymptomatic patients with FKRP mutations suggests that modulating factors may ameliorate the clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344347     DOI: 10.1001/archneur.62.12.1894

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  23 in total

Review 1.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

2.  Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I.

Authors:  Chiara A Boito; Marina Fanin; Bruno F Gavassini; Giovanna Cenacchi; Corrado Angelini; Elena Pegoraro
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

3.  Frequency of the FKRP mutation c.826C>A in isolated hyperCKemia and in limb girdle muscular dystrophy type 2 in German patients.

Authors:  Frank Hanisch; Dörte Grimm; Stephan Zierz; Marcus Deschauer
Journal:  J Neurol       Date:  2009-10-10       Impact factor: 4.849

Review 4.  The genetics of dilated cardiomyopathy.

Authors:  Lisa Dellefave; Elizabeth M McNally
Journal:  Curr Opin Cardiol       Date:  2010-05       Impact factor: 2.161

5.  Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].

Authors:  Chi-Hsien Wang; Yiumo Michael Chan; Ru-Hang Tang; Bin Xiao; Peijuan Lu; Elizabeth Keramaris-Vrantsis; Hui Zheng; Chunping Qiao; Jiangang Jiang; Juan Li; Hsin-I Ma; Qilong Lu; Xiao Xiao
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function.

Authors:  Zhyldyz Kabaeva; Kailyn E Meekhof; Daniel E Michele
Journal:  Hum Mol Genet       Date:  2011-05-30       Impact factor: 6.150

7.  Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I.

Authors:  A Palmieri; R Manara; L Bello; G Mento; L Lazzarini; C Borsato; L Bortolussi; C Angelini; E Pegoraro
Journal:  J Neurol       Date:  2011-02-04       Impact factor: 4.849

8.  Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy.

Authors:  Luca Bello; Paola Melacini; Raffaele Pezzani; Adele D'Amico; Luisa Piva; Emanuela Leonardi; Annalaura Torella; Gianni Soraru; Arianna Palmieri; Gessica Smaniotto; Bruno F Gavassini; Andrea Vianello; Vincenzo Nigro; Enrico Bertini; Corrado Angelini; Silvio C E Tosatto; Elena Pegoraro
Journal:  Eur J Hum Genet       Date:  2012-05-02       Impact factor: 4.246

Review 9.  Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature.

Authors:  D Marques-da-Silva; R Francisco; D Webster; V Dos Reis Ferreira; J Jaeken; T Pulinilkunnil
Journal:  J Inherit Metab Dis       Date:  2017-07-19       Impact factor: 4.982

10.  Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E.

Authors:  Claudio Semplicini; John Vissing; Julia R Dahlqvist; Tanya Stojkovic; Luca Bello; Nanna Witting; Morten Duno; France Leturcq; Cinzia Bertolin; Paola D'Ambrosio; Bruno Eymard; Corrado Angelini; Luisa Politano; Pascal Laforêt; Elena Pegoraro
Journal:  Neurology       Date:  2015-04-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.